Current and emerging therapies to control HIV

The lecture will provide an overview of the most revelant developments in HIV epidemiology, prevention, testing, and treatment. This is relevant in the context of venerology and care around sexually transmitted infections, but also to recognise dermatologic indications and key groups for HIV testing. Pre-exposure prophylaxis to prevent HIV, also called PrEP, now being implemented for 10 years, will be included in the presentation.

Learning Objectives

• Be informed about developments in epidemiology in different parts of the world
• Know which key groups are important for HIV testing and prevention options
• Know about Undetectable is Untransmissable, U=U, and its clinical implications
• Know about the impact of HIV stigma
• Know the pillars of Getting to zero new HIV infections
• Know the new developments in pre-exposure prophylaxis, PrEP, to prevent HIV
• Be able to describe the effects of PrEP on STIs
• Get insights on 10 years after the start of implementation of PrEP
• Be informed about long-term PrEP use and the pipeline of new products